Thursday, 28 October 2010

E-Zentius




E-Zentius may be available in the countries listed below.


Ingredient matches for E-Zentius



Escitalopram

Escitalopram oxalate (a derivative of Escitalopram) is reported as an ingredient of E-Zentius in the following countries:


  • Peru

International Drug Name Search

Wednesday, 20 October 2010

PA Iodo




PA Iodo may be available in the countries listed below.


Ingredient matches for PA Iodo



Iodine

Iodine is reported as an ingredient of PA Iodo in the following countries:


  • Japan

International Drug Name Search

Monday, 18 October 2010

Orudis Topico




Orudis Topico may be available in the countries listed below.


Ingredient matches for Orudis Topico



Ketoprofen

Ketoprofen is reported as an ingredient of Orudis Topico in the following countries:


  • Spain

International Drug Name Search

Saturday, 16 October 2010

Gram Negative Infection Medications


Drugs associated with Gram Negative Infection

The following drugs and medications are in some way related to, or used in the treatment of Gram Negative Infection. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:

Friday, 15 October 2010

Carbomère




Carbomère may be available in the countries listed below.


Ingredient matches for Carbomère



Carbomer

Carbomère (DCF) is also known as Carbomer (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Loratadine Apotex




Loratadine Apotex may be available in the countries listed below.


Ingredient matches for Loratadine Apotex



Loratadine

Loratadine is reported as an ingredient of Loratadine Apotex in the following countries:


  • Netherlands

International Drug Name Search

Tuesday, 12 October 2010

Venlafaxin-Actavis




Venlafaxin-Actavis may be available in the countries listed below.


Ingredient matches for Venlafaxin-Actavis



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Venlafaxin-Actavis in the following countries:


  • Austria

  • Germany

  • Sweden

  • Switzerland

International Drug Name Search

Monday, 11 October 2010

Atracurio




Atracurio may be available in the countries listed below.


Ingredient matches for Atracurio



Atracurium Besilate

Atracurium Besilate is reported as an ingredient of Atracurio in the following countries:


  • Peru

International Drug Name Search

Friday, 8 October 2010

Naloxone HCl-Fresenius




Naloxone HCl-Fresenius may be available in the countries listed below.


Ingredient matches for Naloxone HCl-Fresenius



Naloxone

Naloxone hydrochloride (a derivative of Naloxone) is reported as an ingredient of Naloxone HCl-Fresenius in the following countries:


  • South Africa

International Drug Name Search

Thursday, 7 October 2010

Fentanyl Richter




Fentanyl Richter may be available in the countries listed below.


Ingredient matches for Fentanyl Richter



Fentanyl

Fentanyl is reported as an ingredient of Fentanyl Richter in the following countries:


  • Bulgaria

  • Estonia

International Drug Name Search

Wednesday, 6 October 2010

Tapering Regimen Medications


There are currently no drugs listed for "Tapering Regimen".





Drug List:

Tuesday, 5 October 2010

Ortho Micronor




In the US, Ortho Micronor (norethindrone systemic) is a member of the following drug classes: contraceptives, progestins and is used to treat Abnormal Uterine Bleeding, Amenorrhea, Birth Control and Endometriosis.

US matches:

  • Ortho Micronor

Ingredient matches for Ortho Micronor



Norethisterone

Norethisterone is reported as an ingredient of Ortho Micronor in the following countries:


  • United States

International Drug Name Search

Adolor




Adolor may be available in the countries listed below.


Ingredient matches for Adolor



Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Adolor in the following countries:


  • Russian Federation

International Drug Name Search

Saturday, 2 October 2010

Apo-Lactulose




Apo-Lactulose may be available in the countries listed below.


Ingredient matches for Apo-Lactulose



Lactulose

Lactulose is reported as an ingredient of Apo-Lactulose in the following countries:


  • Canada

International Drug Name Search

Rectiv


Rectiv is a brand name of nitroglycerin, approved by the FDA in the following formulation(s):


RECTIV (nitroglycerin - ointment; intra-anal)



  • Manufacturer: APTALIS PHARMA

    Approval date: June 21, 2011

    Strength(s): 0.4% [RLD]

Has a generic version of Rectiv been approved?


No. There is currently no therapeutically equivalent version of Rectiv available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rectiv. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Nitric oxide donor composition and method for treatment of anal disorders
    Patent 7,189,761
    Issued: March 13, 2007
    Inventor(s): Gorfine; Stephen R.
    A pharmaceutical composition contains a nitric oxide donor and advantageously an optional corticosteroid and/or topical anesthetic. The composition is useful in a method for treating anal disorders such as anal fissure, anal ulcer, hemorrhoidal disease, levator spasm, and so forth, by topical application to or proximate the affected area.
    Patent expiration dates:

    • May 27, 2014
      ✓ 
      Patent use: RECTIV IS A NITRATE VASODILATOR INDICATED FOR THE TREATMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH CHRONIC ANAL FISSURE
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • June 21, 2014 - NEW PRODUCT

See also...

  • Rectiv Consumer Information (Drugs.com)
  • Nitroglycerin Consumer Information (Wolters Kluwer)
  • Nitroglycerin Aerosol Consumer Information (Wolters Kluwer)
  • Nitroglycerin Controlled-Release Capsules Consumer Information (Wolters Kluwer)
  • Nitroglycerin Ointment Consumer Information (Wolters Kluwer)
  • Nitroglycerin Patch Consumer Information (Wolters Kluwer)
  • Nitroglycerin Spray Consumer Information (Wolters Kluwer)
  • Nitroglycerin Tablets Consumer Information (Wolters Kluwer)
  • Nitroglycerin oral/sublingual Consumer Information (Cerner Multum)
  • Nitroglycerin topical Consumer Information (Cerner Multum)
  • Nitroglycerin transdermal Consumer Information (Cerner Multum)
  • Gen-Nitro Advanced Consumer Information (Micromedex)
  • Nitrotab Advanced Consumer Information (Micromedex)
  • Trinipatch 0.2 Advanced Consumer Information (Micromedex)
  • Trinipatch 0.4 Advanced Consumer Information (Micromedex)
  • Trinipatch 0.6 Advanced Consumer Information (Micromedex)
  • Nitroglycerin Intravenous Advanced Consumer Information (Micromedex)
  • Nitroglycerin Oral, Sublingual Advanced Consumer Information (Micromedex)
  • Nitroglycerin Transdermal Advanced Consumer Information (Micromedex)
  • Nitroglycerin AHFS DI Monographs (ASHP)